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Abstract
Background: Human adenovirus type 37 (HAdV-37) is a major etiologic agent of epidemic
keratoconjunctivitis, a common and severe eye infection associated with long-term visual morbidity
due to persistent corneal inflammation. While HAdV-37 has been known for over 20 years as an
important cause, the complete genome sequence of this serotype has yet to be reported. A detailed
bioinformatics analysis of the genome sequence of HAdV-37 is extremely important to
understanding its unique pathogenicity in the eye.
Results:  We sequenced and annotated the complete genome of HAdV-37, and performed
genomic and bioinformatics comparisons with other HAdVs to identify differences that might
underlie the unique corneal tropism of HAdV-37. Global pairwise genome alignment with HAdV-
9, a human species D adenovirus not associated with corneal infection, revealed areas of non-
conserved sequence principally in genes for the virus fiber (site of host cell binding), penton (host
cell internalization signal), hexon (principal viral capsid structural protein), and E3 (site of several
genes that mediate evasion of the host immune system). Phylogenetic analysis revealed close
similarities between predicted proteins from HAdV-37 of species D and HAdVs from species B and
E. However, virtual 2D gel analyses of predicted viral proteins uncovered unexpected differences
in pI and/or size of specific proteins thought to be highly similar by phylogenetics.
Conclusion: This genomic and bioinformatics analysis of the HAdV-37 genome provides a valuable
tool for understanding the corneal tropism of this clinically important virus. Although disparities
between HAdV-37 and other HAdV within species D in genes encoding structural and host
receptor-binding proteins were to some extent expected, differences in the E3 region suggest as
yet unknown roles for this area of the genome. The whole genome comparisons and virtual 2D gel
analyses reported herein suggest potent areas for future studies.
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Background
Adenoviruses (AdV) in the Adenoviridae family have been
divided into four genera: Mastadenovirus, Aviadenovirus,
Atadenovirus, and Siadenovirus [1]. The AdV was first iso-
lated from human adenoids and characterized by two dif-
ferent research teams [2,3]. Human AdV (HAdV) fall
within the genus Mastadenovirus, and cause a wide array of
diseases including acute respiratory disease, gastroenteri-
tis, and ocular surface infection [4-6]. The AdV is non-
enveloped with a double stranded linear genome that
ranges from 26 to 45 kb in size. The icosahedral shaped
capsid ranges from 70 to 100 nanometers in diameter [7].
There are 51 known HAdV serotypes classified into 6 spe-
cies (A-F), based on restriction enzyme analysis and
hemaglutination assays, later confirmed by genome anal-
yses and phylogenetic calculations. Recently, a proposed
fifty-second HAdV serotype was identified and placed into
a new species G [8].
HAdV-37 was originally isolated in 1976 from 62 eyes and
9 genitourinary sites, and subsequently characterized as a
new serotype in 1981 [9]. HAdV-37 is a major etiologic
agent of epidemic keratoconjunctivitis, an explosive and
highly contagious infection of the conjunctiva and cor-
nea, and continues to cause outbreaks [10]. HAdV-37 also
was recently implicated in the pathogenesis of obesity
[11].
Although HAdV species D contains the most serotypes,
complete sequence is available for only 6 – HAdV-9,
HAdV-17, HAdV-26, HAdV-46, HAdV-48, and HAdV-49 –
and none of these have been associated with epidemic
keratoconjunctivitis. In this study, we have sequenced the
complete genome of HAdV-37 and describe its overall
organization. The HAdV-37 genome appears in most
respects typical of other HAdV. However, global pairwise
genome alignments, phylogenetic analyses, and in silico
comparisons of putative viral proteins revealed unique
characteristics of the genome, including areas of non-con-
served sequence in the penton, hexon, E3, and fiber
regions, and differences in size and/or pI of select pre-
dicted HAdV-37 proteins. Understanding the disparities
between the HAdV-37 genome and those of species D
HAdV with dissimilar tissue tropisms may lead to
improved understanding of the genomic determinants of
infection.
Results
General features
The genome length of HAdV-37 was found to be 35,213
base pairs with a base composition of 22.8% A, 20.6% T,
28.3% C, 28.3% G. The 56.6% GC content is on the lower
end of the 57–59% range previously reported for HAdVs
within species D [7]. CpG dinucleotide analysis of HAdV-
37 performed using FUZZNUC software [12] revealed
2389 CpG dinucleotides located within the genome (data
not shown). We identified the predicted 4 early, 2 inter-
mediate, and 5 late transcription regions similar to those
described in other completely sequenced HAdVs (Figure
1), including 35 predicted coding sequences within the
HAdV-37 genome and 8 hypothetical ORFs.
The 5' and 3' termini of the HAdV genome are composed
of inverted terminal repeat (ITR) sequences which for
HAdV-37 were determined to be 159 bp in length. These
sites serve as replication origins for the virus [7]. The motif
located at the extreme termini of the HAdV-37 genome
consists of a CATCATCATAAT, which is unique among
previously sequenced HAdV serotypes. Unique sequences
for the extreme termini have been also observed in other
HAdVs including HAdV-4 [13]. The conserved
ATAATATACC motif within the ITR, which interacts with
the terminal protein precursor (pTP) and polymerase
complex during DNA replication [14], was determined at
base pairs 8–17. A NFIII/Oct-1 recognition site (TAT-
GCAAAT) was identified within the ITR of HAdV-37 at
nucleotides 40–48. A Sp1 binding site (GGGGCGGA) was
identified at nucleotides 73–80. Also, a NFI/CTFI
(TGGGGCGGAGCCA) site was located at overlapping
nucleotides 72–84.
Global pairwise alignment
The mVISTA Limited Area Global Alignment of Nucle-
otides (LAGAN) tool was used to align and compare
paired viral sequences [15]. We compared genomic
sequence correspondence across the whole genome of
HAdV-37 to representative HAdV serotypes from each of
the six HAdV species. Comparison of the HAdV-37
genome with that of HAdV-9, also within species D,
showed a much higher degree of conservation than with
representative HAdVs from other species, but demon-
strated disparity in the penton, hexon, E3, and fiber
regions (Figure 2).
Early genes
E1A is the first transcriptional unit to be expressed during
infection [7]. A common RNA from this region is the
source of several alternatively spliced E1A transcripts [16].
The E1A proteins regulate the transcription of viral and
cellular genes [17,18]. Based on splice donor and acceptor
sites, two putative proteins of 253 and 191 amino acids
with corresponding molecular weights of 28.2 kDa and
21.2 kDa, respectively, were identified in the HAdV-37
genome (Table 1). The HAdV-37 E1A 21.2 kDa protein is
89% identical and 96% similar to the HAdV-9 homologue
(Table 2). A protein corresponding to the previously pre-
dicted 10S protein from previous studies of HAdVs was
not identified in our analysis. The predicted TATA box was
identified at nucleotide 477 and the polyadenylation sig-
nal predicted to be at position 1451.BMC Genomics 2008, 9:213 http://www.biomedcentral.com/1471-2164/9/213
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E1B proteins potentiate viral replication by blocking
apoptosis. E1B 19K blocks the mitochondrial apoptosis
pathway by inactivating BAK and BAX [19]. E1B 55K
inhibits the ability of p53, the host tumor suppressor pro-
tein, to initiate cell cycle arrest [20,21]. The putative TATA
box for the E1B messages was predicted at nucleotide
1525. Two predicted proteins of molecular weights of
21.1 and 55.2 kDa were identified within E1B which cor-
respond to 19- and 55-kDa proteins, respectively, as
reported for HAdV-9. Amino acid sequence analysis
revealed that the predicted 21.1 kDa protein was 99%
identical and 100% similar to the 19 kDa homologue
found in the HAdV-9 genome (Table 2). The polyadenyla-
tion signal for these transcripts was predicted at nucle-
otide 3863.
The E2 region of the genome consists of two transcription
units, E2A and E2B, which encode three proteins that are
required for viral replication [7]. These three proteins are
known as the DNA binding protein (DBP), terminal pro-
tein precursor (pTP), and DNA polymerase. The E2A 54.9
kDa DNA binding protein was identified on the comple-
mentary strand between nucleotides 21305 and 22777.
Also on the complementary strand, but located within the
E2B region, we identified the pTP and DNA polymerase.
The polyadenylation signal for these transcripts was not
identified.
The HAdV E3 region encodes proteins that modulate the
host immune response to infection but are not required
for viral growth in vitro [22,23]. HAdVs within species D
have previously been suggested to encode eight ORFs
within the E3 region [24,25]. Seven classical and one
hypothetical E3 ORFs were identified in our annotation of
HAdV-37. The predicted molecular weights for these are
12.2, 21.8, 18.6, 48.9, 31.6, 10.47, 14.7, and 14.8 kDa.
The TATA box was predicted at nucleotide 25879 with a
TATAAA motif. One polyadenylation signal for this tran-
scription unit was identified at nucleotide 30837.
Open reading frames located in the E4 transcription unit
produce proteins that have a wide variety of functions
[26]. For example, E4 ORF 3 and E4 ORF 6 enhance the
stability of late viral mRNAs and increase their export
Transcriptional map and genome organization of HAdV-37 Figure 1
Transcriptional map and genome organization of HAdV-37. The two horizontal lines define the length of the HAdV-
37 genome with each vertical line within them representing 5000 bps. The block arrows represent the predicted protein cod-
ing regions. The early transcription units (E1-E4) are highlighted. The late transcription units (L1-L5) are designated by paren-
theses.BMC Genomics 2008, 9:213 http://www.biomedcentral.com/1471-2164/9/213
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from the nucleus thereby increasing viral mRNA accumu-
lation in the cytoplasm [26]. E4 ORF 6 also binds to p53
and can block apoptosis [27,28]. We found 6 predicted
ORFs in HAdV-37 located on the complementary strand.
Surprisingly, the E4 ORF 1 from the HAdV-37 genome
was predicted at 65 amino acids in length corresponding
to a molecular weight of 7.4 kDa. In contrast, the HAdV-9
homologue of E4 ORF 1 is 125 amino acids in length, and
contains three regions essential for tumor transformation
(region I, residues 34 to 41; region II, residues 89 to 91;
region III 122 to 125). The E4 ORF 1 of HAdV-9 has struc-
tural similarity to other viral dUTPase enzymes [29,30].
ClustalW analysis of the HAdV-37 E4 ORF 1 compared to
the HAdV-9 homologue revealed a 100% similarity from
residues 61–125, including regions II and III and a trun-
cated dUTPase domain. Further work will be needed to
evaluate the significance of this truncation. The TATA box
for this region was identified at nucleotide 34665 and the
polyadenylation signal at nucleotide 32184.
Global pairwise sequence comparison of HAdV-37 with select serotypes from each of the 6 HAdV species (from top to bot- tom: species A to F) using the online sequence alignment program, mVISTA LAGAN Figure 2
Global pairwise sequence comparison of HAdV-37 with select serotypes from each of the 6 HAdV species 
(from top to bottom: species A to F) using the online sequence alignment program, mVISTA LAGAN. Percent 
sequence conservation is reflected in the height of each data point along the y axis. The penton, hexon, E3, and fiber regions of 
HAdV-37 diverged from HAdV-9, another species D virus.
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Intermediate genes
The intermediate genes of HAdV are IVa2 and IX. The IVa2
protein interacts with L1 52/55K during viral DNA pack-
aging, and assists in the activation of the major late pro-
moter (MLP) [14,31-33]. The HAdV-37 IVa2 gene, found
on the complementary strand, was predicted using the
splice site finder [34], with a 448 amino acid protein and
99% amino acid homology to HAdV-9 IVa2. The IX pro-
tein is a minor capsid protein and also assists in the acti-
vation of the major late promoter [35,36]. A coding
sequence for a 13.7 kDa protein corresponding to IX was
found at nucleotides 3454–3858.
Late genes
The late transcription units of HAdVs are transcribed from
the MLP, which consists of an inverted CAAT box (5777–
5780 bp) and TATA box (5827–5832 bp). The late
mRNAs have been grouped into five families (L1 to L5),
based on the location of the polyadenylation signal. Pro-
teins expressed by these five families are involved in cap-
Table 1: Genome Organization of HAdV-37
Region Gene Product TATA box ATG Stop Protein Length (aa) Poly(A) signal
E1A 21.2 kDa 477 569–932* 1214–1425* 191 1451
28.2 kDa 477 569–1118* 1214–1425* 253 1451
E1B 21.1 kDa 1525 1577 2125 182 3863
55.2 kDa 1525 1882 3369 495 3863
Intermediate IX ND 3454 3858 134 3863
hypothetical 20.5 kDa ND 5765 c 5199 c 188 ND
IVa2 ND 5514–5526*c 3902–5235*c 448 ND
hypothetical 34.76 kDa ND 6514 7503 329 ND
hypothetical 16.57 kDa ND 7786 8253 155 ND
E2A DNA binding protein ND 22777 c 21305 c 490 ND
E2B pTP ND 13495–13503*c 8325–10223*c 635 ND
hypothetical 19.29 kDa ND 8030 c 8563 c 177 ND
DNA Polymerase ND 8280 c 5005 c 1091 ND
hypothetical 11.4 kDa ND 9648 9983 111 ND
L1 52/55K 5827 10638 11762 374 13484
hypothetical 8.58 kDa ND 11781 c 12035 c 84 ND
pIIIa 5827 11785 13476 563 13484
L2 Penton 5827 13530 15089 519 16982
pVII 5827 15093 15683 196 16982
V 5827 15716 16720 334 16982
pX 5827 16750 16974 74 16982
L3 pVI 5827 17030 17734 234 21256
Hexon 5827 17775 20642 949 21256
Protease 5827 20627 21250 207 21256
L4 100K 5827 22794 24992 732 26507
hypothetical 9.29 kDa ND 24181 c 23936 c 81 ND
22K 5827 24775 25188 137 26507
pVIII 5827 25514 26197 227 26507
E3 12.2 kDa 25879 26198 26518 106 30837
21.8 kDa 25879 26472 27062 196 30837
18.6 kDa 25879 27029 27529 166 30837
48.9 kDa 25879 27554 28840 428 30837
hypothetical 31.6 kDa 25879 28867 29709 280 30837
10.4 kDa 25879 29716 29991 91 30837
14.72 kDa 25879 29994 30386 130 30837
14.84 kDa 25879 30379 30771 130 30837
U-exon ND 31022 c 30873 c 49 ND
L5 Fiber 5827 31038 32135 365 32143
E4 7.8 kDa 34665 34564 c 34367 c 65 32184
14.5 kDa 34665 34326 c 33934 c 130 32184
13.56 kDa 34665 33937 c 33584 c 117 32184
14.16 kDa 34665 33581 c 33219 c 120 32184
17.13 kDa 34665 33122 c 32667 c 151 32184
34.1 kDa 34665 33289 c 32411 c 292 32184
Note: c, complementary strand
*, predicted splice sitesBMC Genomics 2008, 9:213 http://www.biomedcentral.com/1471-2164/9/213
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sid production for mature virions [7]. The L1 transcription
unit encodes two proteins, 52/55K and IIIa. The 52/55K
protein is involved in scaffolding of the capsid and there-
fore facilitates virus assembly [37]. The 52/55K protein
also interacts with the intermediate gene product IVa2 to
facilitate DNA packaging [31,33,38]. Polypeptide IIIa is a
structural protein that has been located on the inner cap-
sid surface below the penton base [39]. The 52/55K and
polypeptide IIIa in HAdV-37 were predicted to have
molecular weights of 42.2 kDa and 26.6 kDa, respectively.
The predicted polyadenylation signal for the L1 region
was found at nucleotide 13484.
The proteins encoded on the L2 transcription unit also are
involved in capsid formation [7]. The penton base (pro-
tein III) is found at each of the 12 vertices of the virion [7].
The penton base contains an Arg-Gly-Asp (RGD)
sequence which interacts with host integrins to induce
internalization of the virus [40]. The HAdV-37 penton
base is located at nucleotides 13530–15089. The length of
the protein was predicted to be 519 amino acids with an
estimated molecular weight of 58.4 kDa. The RGD
sequence was located at amino acid position 309–311.
The predicted protein was 100% identical to the previ-
ously published penton base protein identified for HAdV-
37 [41]. The HAdV-37 penton base homologue is 90%
identical and 95% similar to the predicted HAdV-9 pen-
ton base protein (Table 2). The V, VII, and X proteins con-
stitute the HAdV core proteins and facilitate packaging of
viral DNA within the capsid [42]. The HAdV-37 pVII pro-
tein-coding sequence was identified at nucleotides
15093–15683, and the protein was predicted to have a
molecular weight of 21.7 kDa. Proteins with an amino
acid length of 334 and 74 were predicted in the HAdV-37
genome for proteins V and X at nucleotides 15716–16720
and 16750–16974, respectively. The L2 transcripts share a
putative polyadenylation signal at nucleotide 16982.
Three open reading frames corresponding to pVI, hexon,
and protease proteins, with respective molecular weights
of 25.5, 106.8, and 23.4 kDa, were identified within the
L3 transcription unit. The pVI protein contains two
nuclear export signals and two nuclear localization sig-
nals, and plays a role in transporting the hexon protein to
the nucleus for viral assembly [43]. The C terminus of this
protein has also been implicated in regulation of the viral
protease [44]. The HAdV-37 pVI protein was located at
nucleotides 17030–17734. This predicted 234 amino acid
protein was 100% identical to its HAdV-17 homologue.
The hexon protein, the most abundant virion component,
constitutes 240 of the 252 subunits of the protein shell of
the virus [7]. The HAdV-37 hexon protein is 949 amino
acids in length and was nearly identical to that predicted
by Ebner et al. [45]. Our sequence data suggests an addi-
tional 10 amino acids on the N-terminus of the protein,
similar to the predicted hexon gene for HAdV-46 and
HAdV-9, both within species D. The final protein encoded
in the L3 transcription unit is the 23 kDa viral protease
protein. The HAdV-37 homologue was predicted to be
207 amino acids in length. This protein cleaves other viral
proteins allowing for assembly and viral maturation [46],
and the transcript shares a predicted polyadenylation sig-
nal at nucleotide 21256 with other L3 transcripts.
Three L4 proteins, 100 kDa, pVIII, and 22 kDa, were pre-
dicted from our annotation. The 100 kDa protein is a non-
structural protein that assists in the translation of late viral
mRNAs, and inhibits translation of cellular mRNAs
[47,48]. More recently this protein has been implicated as
a scaffold for trimerization of the hexon [49]. The pre-
Table 2: Percent identities/similarities of select HAdV-37 proteins and their homologs
Types/Species E1A 21.2-kDa E1B 21.1-kDa IX DNA binding protein DNA polymerase L1 52/55K Penton
HAdV-12/A 41/65 46/77 56/79 52/78 78/91 78/92 74/86
HAdV-7/B 41/61 53/81 63/85 61/82 82/93 79/88 75/89
HAdV-2/C 35/46 50/78 52/83 57/76 83/93 75/88 68/82
HAdV-9/D 89/96 97/100 99/100 98/99 99/99 99/100 90/95
HAdV-4/E 42/63 50/79 62/86 60/79 83/93 77/87 77/88
HAdV-40/F 35/56 43/72 55/81 51/75 74/90 81/91 73/86
Types/Species Hexon L3 Protease L4 100K L4 pVIII E3 14.7-kDa Fiber E4 14.5-kDa
HAdV-12/A 80/90 79/93 66/83 75/88 35/63 32/66 35/66
HAdV-7/B 85/93 84/93 69/84 82/93 47/68 32/57 42/78
HAdV-2/C 78/90 77/94 69/83 78/91 35/64 36/65 32/71
HAdV-9/D 90/95 100/100 98/99 99/100 98/98 76/89 100/100
HAdV-4/E 85/93 82/93 71/87 84/94 38/62 37/62 40/75
HAdV-40/F 80/92 78/94 66/84 80/90 30/53 31/59 37/66
Percent identities and similarities were calculated using FASTA3 (EMBL-EBI).BMC Genomics 2008, 9:213 http://www.biomedcentral.com/1471-2164/9/213
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dicted 100 kDa protein for HAdV-37 genome was 732
amino acids in length and had a molecular weight of 82.3
kDa. This protein is 98% identical to the published HAdV-
46 100 kDa protein. Protein VIII is a minor capsid protein
that plays a role in the stability of the virion capsid [50].
The pVIII protein of HAdV-37 is 24.6 kDa in molecular
weight and has a 99% identity to the published HAdV-46
pVIII protein. The 22 kDa protein is involved in the pack-
aging of HAdV DNA [51]. A 22 kDa homologue was iden-
tified in HAdV-37 with a predicted protein of 137 amino
acids and molecular weight of 15.8 kDa. Its highest per-
cent identity was to the HAdV-9 22 kDa protein (99%).
The predicted polyadenylation signal for the L4 transcrip-
tion unit is at nucleotide 26507.
The L5 region of the HAdV genome consists entirely of the
fiber protein gene. Fiber protein trimerizes to produce the
functional unit which projects from the 12 penton vertices
of the virus capsid. The fiber protein's carboxyl (C)-termi-
nal globular domain, known as the fiber knob, acts as the
primary ligand for host cell receptor binding. The HAdV-
37 fiber genome sequence was previously reported, and
our predicted protein of 365 amino acids was identical
[52]. The HAdV-37 fiber was only 76% identical and 89%
similar to its homologue in the HAdV-9 genome (Table
2). The polyadenylation signal for this transcript was pre-
dicted at nucleotide 32143. Nucelotide sequence encod-
ing a potential heparan binding site, previously reported
in the fiber shaft of HAdV-5, was not present in the HAdV-
37 fiber gene [53-55].
Virus-associated RNA
Most HAdVs contain two virus-associated (VA) RNA
genes, VA RNAI and VA RNAII. VA RNAI acts against cel-
lular antiviral defense by blocking the activation of the
protein kinase PKR, which when activated turns off pro-
tein synthesis in infected cells [56]. VA RNAII binds to
RNA helicase A and NF90, the latter a component of the
nuclear factor of activated T cells (NFAT) [57]. These VA
RNAs also have been recently shown to suppress RNA
interference [58]. The VA RNA genes for HAdV-37 were
previously identified [59]. Our sequence for VA RNAI is
located at nucleotides 10253–10410 and is 99% identical
to the previously reported sequence, differing by only one
base pair. VA RNAII is located at nucleotides 10471–
10620 and was 100% identical to that previously
reported.
Protein and phylogenetic analysis
The annotation of the HAdV-37 genome allows for its
comparison with other HAdV serotypes within species D
as well as serotypes from other species. Percent identity
and similarity of predicted proteins from each of the
major transcription units were identified for representa-
tive serotypes using Fasta3 [60], and are shown in Table 2.
In this analysis, highest identities outside of species D
were seen with species B (HAdV-7) and species E (HAdV-
4) viruses. Projected protein sequences were then sub-
jected to phylogenetic analysis using Molecular Evolu-
tionary Genetics Analysis (MEGA) 3.1. Bootstrap
confirmed neighbor joining trees also suggested that out-
side of HAdV species D, the serotypes phylogenetically
closest to HAdV-37 were within HAdV species B and E
(Figure 3). We further selected specific proteins for analy-
sis by virtual 2D gel (JVirGel 2.2.3b) [61,62], based on
ClustalW alignments of predicted protein amino acid
sequences comparing serotypes from different HAdV spe-
cies. The accuracy of these virtual 2D gels with regards to
pI has been judged to be within ± 1 pI unit of the true
migration of the physical protein, even when subsequent
post-translational modifications are taken into account
[61,63,64].
Migration patterns for select protein homologues in the
virtual 2D gel showed projected differences in size and/or
pI (See Additional file 1: Supplemental figure 4). The
HAdV-37 DNA binding protein migrated to a predicted
molecular weight of 54.9 kDa and a pI of 8.52 (Table 3
and Additional file 1). The range of pI for the DNA bind-
ing protein among all serotypes tested was from 6.30 to
8.57. The DNA polymerase homologues also revealed
substantial differences in predicted size among the
selected serotypes, and a range in pI from 6.19 to 8.18
(Table 3). HAdV-37 and HAdV-9 polymerase both
migrated to a predicted molecular weight of 125 kDa with
pI's of 6.28 and 6.19, respectively. The HAdV-40 homo-
logue had a predicted pI of 8.14. The predicted molecular
weights of the penton and hexon proteins differed
between serotypes by less than 10 kDa, with a pI range
that was probably within the range of accuracy of the soft-
ware (Table 3 and additional file 1). The L3 protease
homologues migrated to almost identical areas on the vir-
tual gel (Additional file 1), consistent with very high per-
cent similarity between HAdV-37 protease and the other
homologues (93 to 100%, Table 2). In contrast, despite
high percent similarity in the pVIII protein between
HAdV-37 and HAdV-4 (94%), the predicted HAdV-37
pVIII migrated to a pI of 8.80, while the HAdV-4 pVIII
migrated to a pI of 6.22 (Table 2 and Additional file 1).
Further review of the ClustalW alignment for these 2
homologues revealed that despite their high similarity,
there were 3 specific amino acid differences in HAdV-37
that when changed to match the residues in HAdV-4,
resulted in a pI for HAdV-37 of 5.78 (G46D, Q57E,
Q172E, data not shown).
Hypothetical proteins
During annotation of HAdV-37, we located 8 hypothetical
ORFs similar to ORFs predicted from sequences previ-
ously archived in GenBank for other HAdVs (Table 4),BMC Genomics 2008, 9:213 http://www.biomedcentral.com/1471-2164/9/213
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with a blast value for each of less than e-5. GeneMark iden-
tified one of these putative proteins (HAdV-7 13.6 kDa
agnoprotein), and JCVI's annotation engine identified
another (E3B 31.6 kDa), while the rest were identified by
NCBI's ORF finder. Four of the 8 proteins were located on
the complementary strand and 5 were clustered in the area
between the intermediate and late ORFs.
Discussion
We have determined the complete 35,213 base pair
genome of HAdV-37 and identified 35 putative adenovi-
ral genes along with 8 hypothetical ORFs conserved with
at least one other HAdV for each ORF. Comparison of the
HAdV-37 genome to that of HAdV-9, another species D
virus, identified areas of substantial divergence in the pen-
ton, hexon, E3, and fiber regions. Disparities between
these two HAdV species D viruses in genes encoding struc-
Phylogenetic analysis of select HAdV proteins Figure 3
Phylogenetic analysis of select HAdV proteins. Bootstrap confirmed neighbor joining trees designed from MEGA 3.1 
demonstrate phylogenetic relationships between select proteins of HAdV-37 and representative homologues from each of the 
6 HAdV species. The Gonnet protein weight matrix in ClustalX alignment was used, along with complete deletion options. 
Bootstrap confidence levels (500 replicates) are shown as percentages on the relevant branches.
HAdV-37
DNA Binding Protein                              Polymerase                   
Penton                                   Hexon               
Protease                                    pVIII                          
HAdV-37
HAdV-9
HAdV-7
HAdV-4
HAdV-2
HAdV-12
HAdV-40
100
100
96
100
0.02
100
100
HAdV-37
HAdV-9
HAdV-7
HAdV-4
HAdV-2
HAdV-12
HAdV-40
100
100
0.05
HAdV-37
HAdV-9
HAdV-7
HAdV-4
HAdV-2
HAdV-12
HAdV-40
100
90
95
65
0.02
HAdV-9
HAdV-7
HAdV-4
HAdV-12
HAdV-40
HAdV-2
100
100
74
100
0.02
HAdV-37
HAdV-9
HAdV-7
HAdV-4
HAdV-12
HAdV-40
HAdV-2
64
94
0.02
40
100 HAdV-37
HAdV-9
HAdV-7
HAdV-4
HAdV-2
HAdV-12
HAdV-40
100
82
95
95
0.02BMC Genomics 2008, 9:213 http://www.biomedcentral.com/1471-2164/9/213
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tural and host receptor-binding proteins were somewhat
expected and also consistent with known differences in
host tissue tropism, for example the propensity of HAdV-
37 to cause corneal infection, as compared to the associa-
tion of HAdV-9 with urethritis and follicular conjunctivi-
tis [7,65]. Differences between HAdV-9 and 37 in the E3
region, known to be important to immune evasion and
regulation by the virus, but not essential to viral replica-
tion in vitro, suggest as yet undiscovered functions for this
region [22,23]. Divergence in the E3 region, possibly rele-
vant to cellular and tissue specificity during infection,
might be due to positive selection. Sequencing of other
HAdVs within species D would provide further insight
into this area of the HAdV genome.
By phylogenetic analyses and paired comparisons of pre-
dicted proteins, HAdV-37 and HAdV-9 of species D
appeared most closely related to HAdV-7 of species B and
HAdV-4 of species E. Subsequent virtual 2D gel analyses
suggested that for a few proteins, a relatively few amino
acid substitutions between otherwise similar proteins
conferred significant effects on protein charge. If our anal-
yses prove correct, such differences suggest that the func-
tion of such proteins in HAdV species D could be quite
different than previously described for serotypes of other
HAdV species. We acknowledge that our predictions rep-
resent a first approximation of protein characteristics, and
could be subject to over-interpretation for at least two rea-
sons. First, our comparisons to other viruses are only as
reliable as the quality of GenBank viral sequence and
annotation. Secondly, post-translational modifications
may alter both charge and molecular weight of any given
protein. Actual 2D gel analysis will be necessary to con-
firm such predicted differences.
There is growing concern over the accuracy of in silico ORF
prediction in AdVs due to splice variants, as well as incon-
sistencies in banked annotations [66]. To address such
concerns, we compared HAdV-37 annotation using three
different methods: NCBI ORF finder, JCVI's annotation
engine, and GeneMark Heuristic model. We narrowed our
annotation to 35 ORFs by comparison with previously
determined adenoviral annotations, but we consider our
annotation provisional. We identified 8 hypothetical
ORFs similar to those previously identified in other HAdV
species. The very suggestion of hypothetical proteins
implies that our understanding of the HAdV is far from
complete. Transcriptome analysis using viral microarrays
may help to clarify the best annotation [67]. We suggest
that the true transcriptome and proteome of HAdV-37
remain to be determined.
Future sequencing of HAdVs may permit new insights into
viral origin, evolution, and pathogenesis. Recently, HAdV-
22 was isolated for the first time from an outbreak of epi-
demic keratoconjunctivitis. The HAdV-22 isolate was
shown to contain both HAdV-8 fiber gene and HAdV-37
penton base gene [68]. These recombination events
Table 3: Molecular weight/pI of select HAdV-37 proteins and their homologs in other HAdV species
Types/Species DNA binding protein DNA polymerase Penton Base Hexon Protease pVIII
HAdV-12/A 55.0/7.19 135.0/7.50 56.4/6.29 103.0/5.56 23.5/8.50 25.3/9.42
HAdV-7/B 58.2/8.57 136.0/6.87 61.9/5.37 105.7/5.13 23.7/8.69 24.9/6.12
HAdV-2/C 59.1/8.06 120.4/6.22 63.2/5.10 109.2/4.81 23.1/8.68 24.7/9.52
HAdV-9/D 54.8/8.52 125.4/6.19 58.6/5.21 106.3/5.00 23.6/8.61 24.6/8.15
HAdV-37/D 54.9/8.52 125.4/6.28 58.4/5.47 106.8/5.6 23.4/8.61 24.6/8.80
HAdV-4/E 57.2/8.11 116.7/6.33 60.0/4.92 105.4/5.25 23.4/8.13 24.7/6.22
HAdV-40/F 53.3/6.30 135.1/8.14 56.9/5.84 104.0/5.74 23.3/8.68 25.3/8.47
Values in bold represents pI's +/- > 1 pH unit from predicted HAdV-37 proteins
Molecular weight and pI were calculated using JVirGel 2.2.3b
Table 4: Conserved hypothetical HAdV-37 Proteins
Predicted Size Blast Result E-Value Accession Number
20.5 kDa HAdV-5 Hypothetical 12 kDa 5.0 E-20 AAW65500
34.76 kDa HAdV-7 Hypothetical 10.4 kDa 7.0 E-23 AAW33389
16.57 kDa HAdV-7 13.6 Agnoprotein 2.0 E-39 AAT97609
19.29 kDa HAdV-16 Hypothetical 12.6 kDa 9.0 E-12 AAW33435
11.4 kDa HAdV-3 Hypothetical 9.7 kDa 1.0 E-9 AAW33161
8.58 kDa HAdV-7 Hypothetical 11.3 kDa 7.0 E-14 AAT97539
9.29 kDa HAdV-7 Hypothetical protein 2.0 E-20 AAT97549
31.6 kDa HAdV-9 E3 orf3 33.1 kDa 3.0 E-65 CAI05981
Blast results were obtained by blastp using default parameters.BMC Genomics 2008, 9:213 http://www.biomedcentral.com/1471-2164/9/213
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apparently conferred corneal tropism to HAdV-22, a virus
not normally known to infect the cornea. As more HAdV
species D viruses are sequenced, new insights into tropism
and pathogenesis are likely to emerge.
Conclusion
In summary, the complete genome sequence of HAdV-37
was determined and annotated. The organization of the
HAdV-37 genome is similar to other human species D
adenoviruses except in the penton, hexon, E3, and fiber
regions. Phylogenetic analysis of HAdV-37 proteins
revealed close relation to species B and E human adenovi-
ruses, while virtual 2D gel analysis identified differences
in proteins thought to function similarly. The availability
of the HAdV-37 complete genome sequence will facilitate
future studies into the pathogenicity of this important
human pathogen.
Methods
Cells, virus stock, DNA purification
HAdV-37 strain GW was obtained from the American
Type Culture Collection (ATCC). Virus stocks were grown
in A-549 cells (CCL-185), a human alveolar epithelial cell
line that was previously shown to support HAdV-1 virion
production [69]. Virus was purified by CsCl gradient and
subsequent dialysis, and stored at -80°C. DNA extraction
was accomplished by the addition of proteinase K, phe-
nol:chloroform extraction, and finally ethanol precipita-
tion.
Sequencing
Standard PCR methodology was used to amplify regions
of the genome to be sequenced. HAdV type 17 was used as
a reference strain for the design of initial PCR primers. To
close gaps in the sequence and improve overall sequence
quality, Primer 3 [70] and CONSED [71] software were
used to design primers from newly acquired sequence.
Shrimp alkaline phosphatase and exonuclease I treatment
were used to dephosphorylate and degrade residual PCR
primers present together with the PCR products. Sequenc-
ing was performed using the ABI BigDye Terminator v3.1
cycle sequencing kit (Applied Biosystems, Foster City,
CA). The sequencing reaction mixture was purified using
Sephadex G-50 (Sigma Aldrich, St. Louis, MO), and the
reaction products analyzed on ABI 3700 or ABI 3730 XL
capillary electrophoresis DNA sequencers (Applied Bio-
systems). To sequence the viral inverted terminal repeat
(ITR) ends, primers were designed from newly deter-
mined adjacent sequence, and direct sequencing was per-
formed using whole genome DNA as the template [69].
Sequence analysis and genome annotation
Sequence data was filtered using LUCY (JCVI, Rockville,
MD), and data assembly performed with Phred/Phrap,
using default assembly parameters [71-73]. Genome
assembly contained 664 high quality reads with an aver-
age length of 834 bps. The fold coverage for both strands
of the genome was 15. The Phrap average quality score
was 89.0. Genome annotation was performed using JCVI's
automated annotation system [74], and the data was
stored in a MySQL database. Manatee [75] was used to
manually review the data from the annotation engine.
Additionally, we used GeneMark Heuristic Models gene
prediction [76], and NCBI's ORF Finder [77] to examine
the sequence. Open reading frames were searched against
available databases in GenBank, PIR, SWISS-PROT, and
JCVI's CMR database. Splice sites were predicted using a
splice site finder program [34]. An online sequence align-
ment program, mVISTA LAGAN [78] was used for global
pair-wise sequence alignment [15]. CpG analysis was per-
formed with FUZZNUC [12].
Nucleotide sequence accession numbers
The nucleotide sequence for the following HAdVs can be
found in GenBank: HAdV-2 [AC_000007], HAdV-4
[AY487947], HAdV-7 [AC_000018], HAdV-9 [AJ854486],
HAdV-12 [AC_000005], HAdV-17 [AC_000006], HAdV-
40 [L19443]. Previously sequenced HAdV-37 penton base
protein, hexon protein, fiber protein, and VA RNA gene
accession numbers are AAG00906, ABA00016,
AAB71734, and U10679, respectively. The GenBank
accession number for HAdV-37 is DQ900900.
In silico protein analysis
Percent identities and similarities between proteins of
HAdV-37 and other HAdVs were determined using Fasta3
[60,79] and Blastp software [80]. Proteins from the Gen-
Bank database were analyzed by an in silico 2D gel pro-
gram JVirGel 2.2.3b [61]. Phylogenetic analysis was
performed with Molecular Evolutionary Genetics Analysis
(MEGA) 3.1 [81]. Bootstrap confirmed neighbor joining
phylogenetic trees were designed with MEGA 3.1 with 500
replicates.
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